QQQ   289.94 (-0.15%)
AAPL   114.67 (-2.28%)
MSFT   209.52 (-0.41%)
FB   268.02 (-0.62%)
GOOGL   1,724.26 (-0.70%)
AMZN   3,096.66 (-0.09%)
TSLA   522.73 (+6.76%)
NVDA   524.01 (+0.10%)
BABA   270.51 (-0.08%)
CGC   24.94 (+5.14%)
GE   10.12 (+3.69%)
MU   63.78 (+3.88%)
AMD   84.95 (+0.37%)
T   28.60 (+0.99%)
NIO   53.74 (+9.12%)
F   8.86 (+1.37%)
ACB   7.39 (+3.65%)
GILD   59.57 (-0.90%)
NFLX   480.80 (-1.52%)
BA   210.97 (+5.69%)
DIS   146.12 (+3.58%)
QQQ   289.94 (-0.15%)
AAPL   114.67 (-2.28%)
MSFT   209.52 (-0.41%)
FB   268.02 (-0.62%)
GOOGL   1,724.26 (-0.70%)
AMZN   3,096.66 (-0.09%)
TSLA   522.73 (+6.76%)
NVDA   524.01 (+0.10%)
BABA   270.51 (-0.08%)
CGC   24.94 (+5.14%)
GE   10.12 (+3.69%)
MU   63.78 (+3.88%)
AMD   84.95 (+0.37%)
T   28.60 (+0.99%)
NIO   53.74 (+9.12%)
F   8.86 (+1.37%)
ACB   7.39 (+3.65%)
GILD   59.57 (-0.90%)
NFLX   480.80 (-1.52%)
BA   210.97 (+5.69%)
DIS   146.12 (+3.58%)
QQQ   289.94 (-0.15%)
AAPL   114.67 (-2.28%)
MSFT   209.52 (-0.41%)
FB   268.02 (-0.62%)
GOOGL   1,724.26 (-0.70%)
AMZN   3,096.66 (-0.09%)
TSLA   522.73 (+6.76%)
NVDA   524.01 (+0.10%)
BABA   270.51 (-0.08%)
CGC   24.94 (+5.14%)
GE   10.12 (+3.69%)
MU   63.78 (+3.88%)
AMD   84.95 (+0.37%)
T   28.60 (+0.99%)
NIO   53.74 (+9.12%)
F   8.86 (+1.37%)
ACB   7.39 (+3.65%)
GILD   59.57 (-0.90%)
NFLX   480.80 (-1.52%)
BA   210.97 (+5.69%)
DIS   146.12 (+3.58%)
QQQ   289.94 (-0.15%)
AAPL   114.67 (-2.28%)
MSFT   209.52 (-0.41%)
FB   268.02 (-0.62%)
GOOGL   1,724.26 (-0.70%)
AMZN   3,096.66 (-0.09%)
TSLA   522.73 (+6.76%)
NVDA   524.01 (+0.10%)
BABA   270.51 (-0.08%)
CGC   24.94 (+5.14%)
GE   10.12 (+3.69%)
MU   63.78 (+3.88%)
AMD   84.95 (+0.37%)
T   28.60 (+0.99%)
NIO   53.74 (+9.12%)
F   8.86 (+1.37%)
ACB   7.39 (+3.65%)
GILD   59.57 (-0.90%)
NFLX   480.80 (-1.52%)
BA   210.97 (+5.69%)
DIS   146.12 (+3.58%)
Log in
NYSE:EVH

Evolent Health Price Target, Predictions & Analyst Ratings

$14.65
+0.88 (+6.39 %)
(As of 11/23/2020 02:09 PM ET)
Add
Compare
Today's Range
$13.96
Now: $14.65
$14.65
50-Day Range
$9.92
MA: $11.63
$14.14
52-Week Range
$3.50
Now: $14.65
$14.50
Volume22,452 shs
Average Volume1.32 million shs
Market Capitalization$1.26 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.23

Analyst Ratings

Evolent Health (NYSE:EVH) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for Evolent Health in the last 12 months. Their average twelve-month price target is $13.38, predicting that the stock has a possible downside of 8.69%. The high price target for EVH is $20.00 and the low price target for EVH is $8.00. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
EVH Consensus Rating: BuyBuyBuyBuy
EVH Consensus Rating Score: 2.732.732.733.00
EVH Analyst Ratings: 0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
EVH Consensus Price Target: $13.38$13.47$13.56$14.91
EVH Price Target Upside: 8.69% downside41.18% upside42.69% upside74.57% upside

Evolent Health (NYSE:EVH) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Evolent Health (NYSE:EVH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/6/2020Piper SandlerLower Price TargetOverweight$16.00 ➝ $15.00Low
9/30/2020Canaccord GenuityReiterated RatingBuyHigh
8/5/2020Truist FinancialBoost Price TargetBuy$15.00 ➝ $20.00High
8/5/2020Cantor FitzgeraldBoost Price TargetPositive ➝ Neutral$10.00 ➝ $13.00High
7/20/2020Robert W. BairdBoost Price TargetOutperform$10.00 ➝ $12.00Low
7/20/2020SunTrust BanksBoost Price TargetBuy$14.00 ➝ $15.00Low
6/26/2020JPMorgan Chase & Co.Boost Price TargetNeutral$8.00 ➝ $11.00High
6/5/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$13.00 ➝ $8.00Low
1/8/2020Wells Fargo & CompanyLower Price TargetOverweight$19.00 ➝ $17.00Medium
12/18/2019Piper Jaffray CompaniesReiterated RatingBuy$10.15High
12/2/2019KeyCorpLower Price TargetOverweight$20.00 ➝ $10.00High
8/7/2019CowenSet Price TargetBuy$18.00Low
8/7/2019OppenheimerSet Price TargetBuy$15.00Low
10/5/2018SVB LeerinkSet Price TargetOutperform ➝ Buy$35.00Medium
10/4/2018CitigroupBoost Price TargetPositive ➝ Buy$25.00 ➝ $32.00Medium
8/7/2018Jefferies Financial GroupReiterated RatingBuy$25.00High
(Data available from 11/23/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.